With reference to the auditor’s qualified opinion on SAM’s financial statements for Q1 to Q3 of 2024, as submitted by the Company – Q1 and Q2 financial statements on 24 October 2024, and the Q3 financial statements on 18 December 2024 – the auditor stated that they were unable to review the inventory. SAM had explained that the inventory consisted of obsolete and damaged goods that were no longer usable, consequently necessitating sales below cost. However, the auditor was unable to verify this...
Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
TikTok account "tman_settrade" impersonates "T.Man Pharmaceutical Plc." : Unlicensed securities and derivatives business (Disclosure Date : 03/12/2024)
TikTok account "tman_set50" impersonates "T.Man Pharmaceutical Plc." : Unlicensed securities and derivatives business (Disclosure Date : 02/01/2025)
TikTok account "t.mam.pharmaceutic" impersonates "T.Man Pharmaceutical Plc." : Unlicensed securities and derivatives business (Disclosure Date : 10/01/2025)
TikTok account "t.man_pharma" impersonates "T.Man Pharmaceutical Plc." : Unlicensed securities and derivatives business (Disclosure Date : 10/01/2025)
TikTok account "t.man_225" impersonates "T.Man Pharmaceutical Plc." : Unlicensed securities and derivatives business (Disclosure Date : 10/01/2025)
TikTok account "t.man_t67" impersonates "T.Man Pharmaceutical Plc." : Unlicensed securities and derivatives business (Disclosure Date : 10/01/2025)
TikTok account "t.man_pharma102" impersonates "T.Man Pharmaceutical Plc." : Unlicensed securities and derivatives business (Disclosure Date : 10/01/2025)
Facebook page TCP Group impersonates T.C. Pharmaceutical Industries Co., Ltd. : Unlicensed securities and derivatives business (Disclosure Date : 05/08/2024)